000144611 001__ 144611
000144611 005__ 20240229112631.0
000144611 0247_ $$2doi$$a10.3389/fimmu.2019.01848
000144611 0247_ $$2WOS$$aWOS:000479149400001
000144611 0247_ $$2altmetric$$aaltmetric:65168580
000144611 037__ $$aDKFZ-2019-02053
000144611 082__ $$a610
000144611 1001_ $$0P:(DE-He78)2c1968abb9781c0328997892355fa74c$$aMarchini, Antonio$$b0$$eFirst author$$udkfz
000144611 245__ $$aImmune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study
000144611 260__ $$aLausanne$$bFrontiers Media$$c2019
000144611 3367_ $$2DRIVER$$aarticle
000144611 3367_ $$2DataCite$$aOutput Types/Journal article
000144611 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1566568299_407$$xReview Article
000144611 3367_ $$2BibTeX$$aARTICLE
000144611 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000144611 3367_ $$00$$2EndNote$$aJournal Article
000144611 536__ $$0G:(DE-HGF)POF3-316$$a316 - Infections and cancer (POF3-316)$$cPOF3-316$$fPOF III$$x0
000144611 588__ $$aDataset connected to Web of Science, Web of Science, , CrossRef
000144611 7001_ $$aDaeffler, Laurent$$b1
000144611 7001_ $$aPozdeev, Vitaly I.$$b2
000144611 7001_ $$0P:(DE-He78)34bd069ab74ead9ac824c1e0896ecbf0$$aAngelova, Assia$$b3$$udkfz
000144611 7001_ $$0P:(DE-He78)2d7958ea507b0b738619074b38ec6d54$$aRommelaere, Jean$$b4$$eLast author$$udkfz
000144611 773__ $$0PERI:(DE-600)2606827-8$$a10.3389/fimmu.2019.01848$$gVol. 10, p. 1848$$p1848$$tFrontiers in immunology$$v10$$x1664-3224$$y2019
000144611 909CO $$ooai:inrepo02.dkfz.de:144611$$pVDB
000144611 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2c1968abb9781c0328997892355fa74c$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000144611 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)34bd069ab74ead9ac824c1e0896ecbf0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000144611 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2d7958ea507b0b738619074b38ec6d54$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000144611 9131_ $$0G:(DE-HGF)POF3-316$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfections and cancer$$x0
000144611 9141_ $$y2019
000144611 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT IMMUNOL : 2017
000144611 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000144611 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000144611 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000144611 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000144611 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000144611 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000144611 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review
000144611 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ
000144611 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000144611 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000144611 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000144611 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bFRONT IMMUNOL : 2017
000144611 9201_ $$0I:(DE-He78)F010-20160331$$kF010$$lTumorvirologie$$x0
000144611 980__ $$ajournal
000144611 980__ $$aVDB
000144611 980__ $$aI:(DE-He78)F010-20160331
000144611 980__ $$aUNRESTRICTED